Physician

Miguel A Busquets, M.D.

According to 2025 Medicare claims, Miguel Busquets, M.D. (NPI: 1427054808) practices ophthalmology in the Lexington-Fayette, KY market, with the plurality of this provider's patient population coming from Fayette, KY. This provider's primary affiliated billing organization is RETINA AND VITREOUS ASSOCIATES OF KENTUCKY PLLC (NPI: 1619949971; TIN: 610918053) and primary practice location at 40509-1827.

Busquets' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 651 traditional Medicare patients, billed 19,514 HCPCS/CPT codes, and received $2,288,866 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 1,015 prescription claims across 313 beneficiaries totaling $42,949 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 37 records totaling $27,083. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,772,677 to $2,288,866. In contrast, Part D prescription costs have moved from a higher plateau to a lower plateau, from $159,016 to $42,949. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	456	9,996	$1,772,677
2016	423	10,077	$1,686,256
2017	429	9,589	$1,758,892
2018	429	9,516	$1,702,333
2019	346	5,943	$1,150,272
2020	1,328	9,887	$2,728,432
2021	1,232	10,375	$2,643,505
2022	925	10,517	$2,542,726
2023	666	18,363	$2,463,456
2024	651	19,514	$2,288,866

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	279	1,209	$159,016
2016	282	1,146	$141,014
2017	305	1,205	$103,805
2018	318	1,411	$124,630
2019	224	960	$107,309
2020	297	667	$64,571
2021	288	592	$71,059
2022	290	662	$51,193
2023	231	653	$52,145
2024	313	1,015	$42,949

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	192	1,908	$656
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	167	210	$84
67028	Injection of drug into eye	288	1,221	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	358	631	$60
92134	Imaging of retina	609	1,889	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	136	5,083	$5,840
Alphagan P	Brimonidine Tartrate	22	805	$4,990
Brimonidine Tartrate	Brimonidine Tartrate	223	10,875	$3,988
Difluprednate	Difluprednate	53	1,672	$3,934
Bromfenac Sodium	Bromfenac Sodium	22	711	$2,665

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	35	$18,994	Alcon Research LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$8,089	Apellis Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Miguel A. Busquets, M.D.?

Tedicare shows public-source Medicare data for Miguel A. Busquets, M.D. (NPI 1427054808), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Miguel A. Busquets, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Miguel A. Busquets, M.D.?

Miguel A. Busquets, M.D. is linked to RETINA AND VITREOUS ASSOCIATES OF KENTUCKY PLLC (billing NPI 1619949971) in the available physician profile data.

Does Miguel A. Busquets, M.D. have Open Payments data?

Miguel A. Busquets, M.D. has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.